Daniel Arias
Stock Analyst at Stifel
(5.00)
# 11
Out of 4,876 analysts
153
Total ratings
52.81%
Success rate
147.97%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintains: Hold | $57 → $48 | $41.53 | +15.58% | 7 | May 8, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $51.85 | +15.72% | 11 | May 8, 2025 | |
| GH Guardant Health | Maintains: Buy | $53 → $60 | $50.77 | +18.18% | 3 | May 1, 2025 | |
| AVTR Avantor | Downgrades: Hold | $26 → $14 | $13.72 | +2.04% | 9 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $412.44 | +50.32% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $200.61 | +29.60% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $2.27 | +297.35% | 2 | Mar 12, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $11.61 | +55.04% | 6 | Feb 13, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $6.79 | -11.63% | 2 | Nov 13, 2024 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,550 → $1,450 | $1,193.42 | +21.50% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $67.64 | -3.90% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $67 | $53.89 | +24.33% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $355.46 | +1.28% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $119.73 | +26.12% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $47.96 | -3.36% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.42 | +313.22% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $123.95 | +67.00% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $95 → $110 | $98.24 | +11.97% | 1 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $94.51 | +111.62% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.52 | +98.41% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $2.71 | +269.69% | 2 | May 31, 2022 |
Bruker
May 8, 2025
Maintains: Hold
Price Target: $57 → $48
Current: $41.53
Upside: +15.58%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $51.85
Upside: +15.72%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $53 → $60
Current: $50.77
Upside: +18.18%
Avantor
Apr 28, 2025
Downgrades: Hold
Price Target: $26 → $14
Current: $13.72
Upside: +2.04%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $412.44
Upside: +50.32%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $200.61
Upside: +29.60%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $2.27
Upside: +297.35%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $11.61
Upside: +55.04%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $6.79
Upside: -11.63%
Mettler-Toledo International
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,193.42
Upside: +21.50%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $67.64
Upside: -3.90%
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $53.89
Upside: +24.33%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $355.46
Upside: +1.28%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $119.73
Upside: +26.12%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $47.96
Upside: -3.36%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $2.42
Upside: +313.22%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $123.95
Upside: +67.00%
Feb 2, 2024
Maintains: Hold
Price Target: $95 → $110
Current: $98.24
Upside: +11.97%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $94.51
Upside: +111.62%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.52
Upside: +98.41%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $2.71
Upside: +269.69%